← Eichor
Study identifier: NCT06920459 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Zimmer Biomet Shoulder Arthroplasty PMCF Study

Condition: Shoulder Fractures · Shoulder Arthritis Osteoarthritis · Shoulder Injury  ·  Sponsor: Zimmer Biomet

PhaseN/A
Planned participants50
Who can joinAll sexes, 20 Years to no upper limit
Healthy volunteersNo

About this study

This is a multicenter, prospective, non-controlled post market surveillance study. The objectives of this study are to confirm the safety, performance, and clinical benefits of the Zimmer Biomet Shoulder Arthroplasty systems in primary anatomic shoulder arthroplasty and its instrumentation. Safety of the systems will be assessed by monitoring the frequency and incidence of adverse events. The performance and clinical benefits will be evaluated by assessment of the overall pain and functional performance, qualify of life, and radiographic parameters of all enrolled study subjects.

This description comes directly from the study's public registry record.

Talk to the study team

Carina Hafner  ·  +41 79 707 30 93  ·  carina.hafner@zimmerbiomet.com

Lisa To  ·  Lisa.To@zimmerbiomet.com

Always discuss trial participation with your own doctor first.

Locations (2)

ARCUS Kliniken PforzheimPforzheim, GermanyRecruiting
Meander Medisch CentrumAmersfoort, TZ, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06920459